Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cholesterol/Lipid Disorders
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cholesterol/Lipid Disorders
    Certain Biomarkers Have Limitations in Predicting Cardiovascular Events - (DGNews)
    TopAbstracts in Cholesterol/Lipid Disorders 06/25/2009 - (DGNews)
    Treatment With Physiological Levels of Growth Hormone Fails to Show Benefit on Cardiovascular Parameters: Presented at ENDO 09 - (DGDispatch)
    Genetically elevated lipoprotein(a) and increased risk of myocardial infarction - (JAMA)
    TopAbstracts in Cholesterol/Lipid Disorders 06/11/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Cholesterol/Lipid Disorders
      The Evolution of Cardiometabolic Risk Reduction and Mixed Dyslipidemia: Examining the Role of Chronic Obesity Management
      Treatment of Mixed Dyslipidemia
      Artifactual Laboratory Abnormalities in Patients with Paraproteinemia
      Issues in Cardiovascular & Metabolic Risk Management: Highlights from ENDO 08
      Dyslipidemia in Children and Adolescents

      Webcasts/CME archive

       Recent cases - Cholesterol/Lipid Disorders
        Marked Aortic Valve Stenosis Progression After Receiving Long-Term Aggressive Cholesterol-Lowering Therapy Using Low-Density Lipoprotein Apheresis in a Patient With Familial Hypercholesterolemia
        Acute Myocardial Infarction in an 18 Year Old South Indian Girl with Familial Hypercholesterolemia: A Case Report
        Eruptive Xanthomas and Acute Pancreatitis in a Patient with Hypertriglyceridemia
        Abetalipoproteinemia: Two Case Reports and a Literature Review
        Familial Hypercholesterolemia with Coarctation of Aorta

        Cases archive
          




        my personal edition > cholesterol/lipid disorders > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        NICE Issues Guidance on Lowering Cholesterol for People at High Risk of Cardiovascular Disease in UK

          LONDON -- May 29, 2008 -- The National Institute for Health and Clinical Excellence (NICE) and the National Collaborating Centre for Primary Care have issued new guidance to the National Health Service in England and Wales on the identification of people at risk of cardiovascular disease (CVD) and on the use of lipid lowering drugs to reduce that risk.

          The NICE guidelines address the identification of those at high risk (primary prevention) and the modification of lipids in these people and in people with established CVD (secondary prevention).

          Guidelines for the primary prevention of CVD include using a modified Framingham 1991, 10-year risk equation to identify people aged 40 to 75 years who are likely to be at high risk of CVD. Also, before offering drugs to reduce cholesterol levels, all other modifiable risk factors should be considered and their management optimised if possible.

          Statin therapy is recommended as part of the management strategy for the primary prevention of CVD for adults who have a 20% or greater 10-year risk of developing CVD. Treatment should be initiated with simvastatin 40 mg. If there are potential drug interactions, or simvastatin 40 mg is contraindicated, a lower dose or alternative preparation such as pravastatin may be chosen.

          Guidelines on the secondary prevention of CVD recommend that drugs be used to reduce cholesterol levels and should not delayed by management of modifiable risk factors. For adults with clinical evidence of CVD, statin therapy is recommended.

          John Robson, MD, General Practitioner and Chair of the Guideline Development Group, NICE, said, "This [guideline] is a major public health initiative and will be a welcome addition to the Government's vascular programme as it ensures an efficient and equitable method of targeting treatment to those most likely to benefit."


          SOURCE: National Institute for Health and Clinical Excellence




        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send